KNOWLEDGE BANK

Interviews

Advancing Pharma Innovation & Drug Development | Thermo Fisher Scientific | ISPE 2026 | Pharma Focus Asia

Senior Director, Head of Business Development APAC, Thermo Fisher Scientific
Koji Tanimoto is Senior Director of Biotech Account Management APAC at Thermo Fisher Scientifics Pharma Services Group Previously he served as Senior Director and Head of Business Development for Asia Pacific and Japan at Patheon also holding the title of Director at Patheon In Japan Since he led business development across both Patheons CDMO operations and Fisher Clinical Services clinical trial...

Articles

Why tier-2 and tier-3 cities are not included for clinical research

India is rapidly emerging as a global hub for clinical research with many international pharmaceutical companies and research organisations choosing the country as a site for their clinical trials

Research Insights

Efficacy of the Combination of Monoclonal Antibodies Against the SARS-CoV-2 Beta and Delta Variants

The pandemic of severe acute respiratory syndrome coronavirus SARSCoV is currently the biggest healthcare issue worldwide This study aimed to develop a monoclonal antibody against SARSCoV from B cells of recovered COVID patients which might have beneficial therapeutic purposes for COVID patients

Case Studies

Evaluation of A Sequencing Batch Reactor Sewage Treatment Rig For Investigating The Fate of Radioactively Labelled Pharmaceuticals: A Case Study of Propranolol

Abstract Pharmaceuticals are frequently detected in the aquatic environment and have potentially damaging effects Effluents from sewage treatment plants STPs are major sources of these substances The use of sequencing batch reactor SBR STPs involving cycling between aerobic and anoxic conditions to promote nitrification and denitrification is increasin

Techno Trends

Biogen Develops QALSODY®, the First Therapy to Treat a Rare, Genetic Form of ALS

Biogen has developed QALSODY a groundbreaking therapy for adults with amyotrophic lateral sclerosis linked to a mutation in the superoxide dismutase gene

White Papers

Cloud Computing in the Laboratory Informatics Solutions and Validation Approaches

In the modern business environment, a significant portion of work is conducted using computerized systems. Many solutions are used to complete tasks, including simple desktop programs like email and Microsoft Office to enterprise-wide, global systems like ERP (Enterprise Resource Planning), MES (Manufacturing Execution System), and LIMS

TOP ARTICLES

1

Advanced Drug Delivery Systems for Chronic Liver Disease Management

Jyothi U. Menon

Jyothi U Menon received her PhD in Biomedical Engineering from the University of Texas (UT) Arlington and UT Southwestern Medical Center joint program. She completed her postdoctoral training at the University of Oxford, UK. She is currently an Associate Professor in the College of Pharmacy at the University of Rhode Island where her research focus is on targeted drug delivery systems to treat lung and liver diseases, and in vitro disease modeling.

 

2

Innovative Tool For Drug Design And Development

Subash Senthil

S.Subash awarded 2 best poster presentation awards and secured 1st place in Poster presentation. I published three articles in national and international peer reviewed journal. And, also attend many conferences to upgrade knowledge.

 

3

Machine Learning for New Drugs

Sneha Rai

Sneha Rai completed her Ph.D. from Computational and Structural Biology Lab., Department of Biological Sciences and Engineering at Netaji Subhas Institute of Technology (DU). She did masters in Bioinformatics from Banaras Hindu University and holds six years of bioinformatics research experience. Her area of interest includes structural bioinformatics, systems biology, protein/gene network analysis, data mining, computer aided drug designing, computational genomics, NGS data analysis, variant analysis and their clinical interpretation.

 

Venugopal Bhatia

Venugopal Bhatia graduated from NSIT in 2019 with a B.E. in Biotechnology. During his undergraduate studies he was involved as an undergraduate researcher at the Computational and Structural Biology Laboratory and worked on two projects which were later published in Nature Scientific Reports and Elsevier Computational Biology and Chemistry. After a brief stint in industry, he's now pursuing his Master's at Yale.

 

Sonika Bhatnagar

Sonika Bhatnagar, Ph.D. (Biophysics), AIIMS works in the broad area of computational molecular biology. Her laboratory uses techniques of drug target selection, drug design & discovery, machine learning, and integrative genomics & proteomics towards Cardiovascular disease drug design and infectious disease therapeutics.

 

4

Metabolic Stability

Rajesh Sonti

Rajesh Sonti is working as an Assistant Professor since Feb 2020 in Department of Pharmaceutical Analysis, National Institute of Pharmaceutical Education and Research (NIPER)-Hyderabad. He completed PhD from IISc, Bangalore and later worked as a post doc in University of Basel and EPFL-Lausanne for 6.5 years.

 

Venkata Rao Kaki

Venkata Rao Kaki is working as an Assistant Professor in Department of Chemical Sciences (medicinal chemistry/natural products),NIPER-Hyderabad. He completed PhD from Panjab university, Chandigarh. He has 4 years industrial and 8 years of academic experience.

 

Siva Nageswara Rao Gajula

Siva Nageswara Rao Gajulais pursuing PhD in Department of Pharmaceutical Analysis, NIPER-Hyderabad. He is working in the scientific areas:Drug Metabolism and Pharmacokinetics (DMPK), biomarkers and drug-drug interactions. He did M.S. (Pharm.) in department of pharmaceutical Analysisfrom NIPER-Ahmedabad.

 

Nadimpalli Nimisha

Pursued M.S. (Pharm.), National Institute of Pharmaceutical Education and Research (NIPER)

Megha Sajakumar Pillai

Megha Sajakumar Pillai pursued M.S. (Pharm.) in department of pharmaceutical Analysis, NIPER-Hyderabad. She is currently pursuing PhD in NIPER-Ahmedabad.

 

5

press releasesRead more...

Asia–US Clinical Data Collaboration Built on IHH's Clinical Data

Mitsui Co Ltd Mitsui Head Office Tokyo President and CEO Kenichi Hori has entered a service agreement with Oncoshot Pte Ltd Oncoshot on the utilization of Oncoshots proprietary clinical

Teijin, Teijin Regenet and Shinshu University Hospital Launch Joint Research to Strengthen CAR-T Cell Therapy Manufacturing Capabilities in Japan

Teijin Limited Teijin Regenet Co Ltd and Shinshu University Hospital today announced that they have entered into a joint research agreement regarding manufacturing technologies for cell and gene

VVMF, Australia’s First Viral Vector CDMO Receives TGA Manufacturing Licence

Viral Vector Manufacturing Facility Pty Ltd VVMF Australias first viral vector Contract Development and Manufacturing Organisation CDMO advises that the Therapeutic Goods Administration TGA

Oral insulin drug achieves a critical milestone

University of Sydney biotechnology spinout Endo Axiom is conducting its first study in human subjects to assess the safety and tolerability of different doses of oral insulin in healthy volunteers

Transcenta Therapeutics and WuXi Biologics Enter into Strategic Collaboration to Accelerate Commercialization of HiCB Continuous Bioprocessing Technologies

Transcenta Therapeutics HKEX a global clinicalstage biopharmaceutical company with fully integrated capabilities in discovery RD and process development of antibodybased therapeutics

1cBio and Lee's Pharmaceutical Holdings Limited Enter into Exclusive Licensing Agreement to Develop and Commercialize 1cBio's PARP1 Inhibitor OC-3 for Oncology in Greater China

cBio a biopharmaceutical company focused on discovering and developing innovative therapies for serious and underserved conditions including oncology and metabolic diseases and Lees Pharmaceutical

EventsRead more...

14 - 15

Sep 2026

16th American DDF Summit

Omni Boston Hotel at the Seapo...

15 - 17

Sep 2026

COPD Drug Development Summit 2026

Street, Boston, MA 02210, USA

21 - 23

Sep 2026

21 - 23

Sep 2026

Cancer R&D World Conference

Hilton Garden Inn Miami Dolphi...

22 - 23

Sep 2026

22 - 24

Sep 2026

28 - 01

Sep 2026

LATEST NEWSRead more...

CordenPharma Expands Aseptic Fill-Finish Capacity to 500 Million Sterile Injectable Units Annually

CordenPharma is expanding its sterile injectable manufacturing capacity at its Caponago site in Milan Italy through a multiyear investment programme

Exegenesis Bio Enters into Collaboration with Modalis to Advance MDL-201 for Duchenne Muscular Dystrophy

Exegenesis Bio and Modalis Therapeutics have entered into a research collaboration and licence agreement to advance MDL an investigational treatment for Duchenne muscular dystrophy DMD

Schrödinger Forms Tectora Therapeutics to Advance Immunology and Inflammation Programmes

Schrdinger has announced the formation of Tectora Therapeutics The company was cofounded by Schrdinger New Enterprise Associates NEA and RA Capital Management

MannKind and Rose Pharma Partner to Develop Inhaled GLP-1 for Weight Management

MannKind and Rose Pharma have entered into a worldwide licensing and collaboration agreement to develop ROSE Technosphere an investigational inhaled GLP therapy for weight management

Rezubio Advances RZ-520 into Phase 1 Clinical Trial Following FDA and NMPA Clearances

Rezubio has announced the first cohort dosing in its Phase clinical trial of RZ following Investigational New Drug IND clearances from the US Food and Drug Administration FDA and Chinas National Medical

ZANVASTRO approved by FDA as first disease-modifying treatment for Alexander disease

Ionis Pharmaceuticals has received approval from the US Food and Drug Administration FDA for ZANVASTRO zilganersen to treat Alexander disease AxD in paediatric and adult patients